Refine Search
(108)
(202)
(680)
(1596)

OpportunityAnalyzer: Immune Thrombocytopenia (ITP) – Opportunity Analysis and Forecasts to 2025

  • $10,995
  • February 2017
Add to Basket Quick View Add to Saved List

Immune Thrombocytopenia (ITP) is an auto-immune-related bleeding disorder characterized by a low platelet count. Patients with severe ITP often experience fatigue, bruising, and reduced quality of life. Although most ITP cases are not fatal, ap...

PharmaPoint: Rheumatoid Arthritis – Global Drug Forecast and Market Analysis to 2025

  • $10,995
  • February 2017
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over six million individuals in the 8MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, and Austr...

OpportunityAnalyzer: Cystic Fibrosis – Opportunity Analysis and Forecasts to 2025

  • $10,995
  • April 2017
Add to Basket Quick View Add to Saved List

Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which codes for the CFTR protein. As a multisystem condition, CF patients show great heterogeneit...

PharmaPoint: Ulcerative Colitis– Global Drug Forecast and Market Analysis to 2025

  • $10,995
  • January 2017
Add to Basket Quick View Add to Saved List

Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of the colon and rectum. As a result, the colon's ability to absorb water is decreased, which leads to progressive loosening of the...

PharmaPoint: Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2022

  • $10,995
  • March 2013
Add to Basket Quick View Add to Saved List

Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current dis...

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022

  • $10,995
  • February 2013
Add to Basket Quick View Add to Saved List

Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics – Global Drug Forecast and Market Analysis to 2025

  • $10,995
  • December 2016
Add to Basket Quick View Add to Saved List

The hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections of the liver and, if left untreated, can result in fibrosis, permanent liver damage (cirrhosis), HCC, and eventually death. A member of the Fla...

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022

  • $10,995
  • December 2012
Add to Basket Quick View Add to Saved List

GlobalData's report "Prostate Cancer - Global Drug Forecast and Market Analysis to 2022" provides comprehensive information on prostate cancer therapeutics, highlighting the treatment guidelines and identifies and analyses the key...

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

  • $10,995
  • May 2013
Add to Basket Quick View Add to Saved List

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. T...

PharmaPoint: Meningococcal Vaccines – Global Drug Forecast and Market Analysis to 2025

  • $10,995
  • May 2016
Add to Basket Quick View Add to Saved List

Neisseria meningitidis is a Gram-negative, encapsulated diplococcal bacterium and is the causative agent for invasive meningococcal disease. Although relatively rare around the globe, invasive meningococcal disease is widely feared because of i...

PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy – Global Drug Forecast and Market Analysis to 2024

  • $10,995
  • December 2015
Add to Basket Quick View Add to Saved List

Congenital hemophilia A and B are bleeding disorders that are caused by genetic X-linked deficiencies in the blood clotting Factors VIII and IX, respectively. Hemophilia manifests as mild, moderate, or severe inability to form clots, depending ...

PharmaPoint: Hepatitis B Virus (HBV) Therapeutics – Global Drug Forecast and Market Analysis to 2024

  • $10,995
  • January 2016
Add to Basket Quick View Add to Saved List

Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious glob...

PharmaPoint: Peripheral Artery Disease — Global Drug Forecast and Market Analysis to 2024

  • $10,995
  • October 2015
Add to Basket Quick View Add to Saved List

In the 2014 base year, the global PAD market was worth approximately $543.4m, including both branded and generic drugs. By 2024, GlobalData expects that the global PAD market will experience significant expansion, with a Compound Annual Growth ...

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

  • $10,995
  • April 2016
Add to Basket Quick View Add to Saved List

Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Altho...

PharmaPoint: Atopic Dermatitis – Global Drug Forecast and Market Analysis to 2024

  • $10,995
  • November 2015
Add to Basket Quick View Add to Saved List

Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for ...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks